Cowen Encouraged About Syndax Pharmaceuticals Inc's (SNDX) Positive Data Readouts in NSCLC

Share
Cowen Encouraged About Syndax Pharmaceuticals Inc's (SNDX) Positive Data Readouts in NSCLC

SNDX has been the subject of several recent research reports.

Syndax Pharmaceuticals (NASDAQ:SNDX) opened at 13.58 on Friday. They issued a "buy" rating on the stock. Finally, FBR & Co began coverage on Syndax Pharmaceuticals in a research report on Thursday, March 16th. They set an "outperform" rating on the stock. Nomura initiated coverage on Syndax Pharmaceuticals in a research note on Wednesday, March 1st. They set a buy rating and a $27.00 price target for the company. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company's stock. The recent change has given its price a -2.82% deficit over SMA 50 and -7.08% deficit over its 52-week high. The stock had a trading volume of 554,845 shares. (SNDX) has the trading volume of 4.27 Million shares with the average trading volume of 627440 shares.

Looking at the current price of the stock and the 52 week high and low, it suggests that the stock is likely to go Down in the future. The 200 SMA is considered so critically important a trend indicator that the event of the 50-day SMA crossing to the downside of the 200-day SMA is referred to as a death cross, signaling a serious bear market in a stock, index or other investment. (SNDX) now has a value of $13.58 while the company's 52 week low is at $6.31, the shares dropped to the 52 week low on 01/23/17. The company reported ($0.71) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.74) by $0.03. The company had revenue of $0.31 million for the quarter, compared to the consensus estimate of $0.31 million. Syndax Pharmaceuticals had a negative return on equity of 306.05% and a negative net margin of 3,388.98%. Syndax Pharmaceuticals Inc (NASDAQ:SNDX) has risen 6.00% since April 18, 2017 and is uptrending.

COPYRIGHT VIOLATION WARNING: This article was first posted by Community Financial News and is owned by of Community Financial News. If you are reading this story on another publication, it was stolen and republished in violation of United States & global trademark & copyright laws. The correct version of this story can be accessed at https://www.chaffeybreeze.com/2017/05/17/syndax-pharmaceuticals-inc-sndx-downgraded-by-zacks-investment-research-to-hold.html. Point72 Asset Management L.P. bought a new stake in shares of Syndax Pharmaceuticals during the first quarter worth about $1,358,000.

If you look at the company's income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, SNDX earned gross profit of 0, in 2015 0 gross profit, while in 2016 Syndax Pharmaceuticals, Inc. Sphera Funds Management LTD. purchased a new stake in Syndax Pharmaceuticals during the third quarter valued at $2,521,000. Going from the most negative analyst price target to above consensus is one thing. Alyeska Investment Group L.P. now owns 225,000 shares of the company's stock valued at $1,613,000 after buying an additional 56,228 shares during the last quarter.

COPYRIGHT VIOLATION NOTICE: "Syndax Pharmaceuticals (SNDX) Getting Somewhat Positive Press Coverage, Study Shows" was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. The stock price recently experienced a 5-day gain of 62.25% with 1.15 average true range (ATR).

Syndax is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies.

Share

Advertisement

Related Posts

Karbonn Aura Power 4G Plus
Now one does not need to worry about the life of their phone because come what may the Aura Power 4G plus will stand by you. The Karbonn Aura Power 4G Plus will be available in brick and mortar shops and online retailers too.

Titan's riverbeds show a terrain built more like Mars than Earth
It has methane rivers, clouds and haze, mountains and valleys - all of which superficially remind observers of Earth. There is evidence liquid once flowed on the surface of Mars.

Autopsy being conducted on body of Chris Cornell
Reps from Live Nation confirmed in a release on Thursday morning that the band has canceled that show. Soundgarden frontman Chris Cornell passed away earlier today at the age of 52.

"Sanctuary City" Bill headed to Gov. Abbott's desk
Currently, these are legally optional and allow law enforcement officers to evaluate detainer requests on a case by case basis. Abbott is likely to sign the bill even before the Legislature adjourns later this month.

Russia Warns Against The Intimidation Of North Korea
Security Council resolutions, saying it was a test of its capability to carry a "large-size heavy nuclear warhead". North Korea conducted its latest ballistic missile test on Sunday in defiance of U.N.

Michael Vick to play in trial game for American Flag Football League
Every single year, National Football League teams cut 800 guys. "We need less than 100 players to field eight teams". However, they'll have seven-man teams and magnetic flags with sensors showing exactly where a player is down.

Porti e aeroporti, nuove regole Ue semplificano investimenti
L'obiettivo è di promuovere indirettamente gli investimenti pubblici in un momento economico sempre fragile. Gli aiuti di Stato creano spesso problemi lì dove, al termine dell'indagine, non si riscontrano.

Biz History Netherlands names program scheduler
Both Huiskamp and Schouwenaar will report to Jessica Haagmans, regional director for Benelux. A+E Networks UK now broadcasts History and Crime+Investigation (CI) to a pan-European feed.

President Trump Prepares to Visit Israel
Israeli Defense Minister Avigdor Liberman paid tribute to U.S. -Israel ties in posts in both English and Hebrew on Twitter. The relationship with the U.S. "is unprecedented in its contribution to our strength".

U.S. denied visas to 40 gay Chechen refugees
While the reports drew widespread condemnation, including sharp rebuke from U.S. Nikki Haley, the White House was conspicuously quiet on the matter.

© 2015 Vivere Milano. All Rights reserved.